<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="195">
<accession>Q13435</accession>
<accession>A8K485</accession>
<accession>B4DT19</accession>
<accession>Q7L4T5</accession>
<accession>Q7Z627</accession>
<accession>Q969K1</accession>
<accession>Q96CM6</accession>
<accession>Q9BWD2</accession>
<name>SF3B2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Splicing factor 3B subunit 2</fullName>
</recommendedName>
<alternativeName>
<fullName>Pre-mRNA-splicing factor SF3b 145 kDa subunit</fullName>
<shortName>SF3b145</shortName>
</alternativeName>
<alternativeName>
<fullName>Spliceosome-associated protein 145</fullName>
<shortName>SAP 145</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SF3B2</name>
<name type="synonym">SAP145</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lymphoblast</tissue>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Eye</tissue>
<tissue>Kidney</tissue>
<tissue>Lung</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Genes Dev." volume="10" first="233" last="243">
<title>Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A.</title>
<authorList>
<person name="Gozani O."/>
<person name="Feld R."/>
<person name="Reed R."/>
</authorList>
<dbReference type="PubMed" id="8566756"/>
<dbReference type="DOI" id="10.1101/gad.10.2.233"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 9-895</scope>
<scope>PROTEIN SEQUENCE OF 174-182 AND 817-840</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="779" last="787">
<title>Functional association of U2 snRNP with the ATP-independent spliceosomal complex E.</title>
<authorList>
<person name="Das R."/>
<person name="Zhou Z."/>
<person name="Reed R."/>
</authorList>
<dbReference type="PubMed" id="10882114"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80318-4"/>
</citation>
<scope>CHARACTERIZATION OF THE SPLICEOSOME</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="4978" last="4988">
<title>Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein.</title>
<authorList>
<person name="Will C.L."/>
<person name="Urlaub H."/>
<person name="Achsel T."/>
<person name="Gentzel M."/>
<person name="Wilm M."/>
<person name="Luehrmann R."/>
</authorList>
<dbReference type="PubMed" id="12234937"/>
<dbReference type="DOI" id="10.1093/emboj/cdf480"/>
</citation>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="RNA" volume="8" first="426" last="439">
<title>Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.</title>
<authorList>
<person name="Jurica M.S."/>
<person name="Licklider L.J."/>
<person name="Gygi S.P."/>
<person name="Grigorieff N."/>
<person name="Moore M.J."/>
</authorList>
<dbReference type="PubMed" id="11991638"/>
<dbReference type="DOI" id="10.1017/s1355838202021088"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE SPLICEOSOMAL C COMPLEX</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Science" volume="300" first="980" last="984">
<title>Molecular architecture of the multiprotein splicing factor SF3b.</title>
<authorList>
<person name="Golas M.M."/>
<person name="Sander B."/>
<person name="Will C.L."/>
<person name="Luhrmann R."/>
<person name="Stark H."/>
</authorList>
<dbReference type="PubMed" id="12738865"/>
<dbReference type="DOI" id="10.1126/science.1084155"/>
</citation>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
<scope>ELECTRON MICROSCOPY OF THE SF3B COMPLEX</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="RNA" volume="10" first="929" last="941">
<title>The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.</title>
<authorList>
<person name="Will C.L."/>
<person name="Schneider C."/>
<person name="Hossbach M."/>
<person name="Urlaub H."/>
<person name="Rauhut R."/>
<person name="Elbashir S."/>
<person name="Tuschl T."/>
<person name="Luehrmann R."/>
</authorList>
<dbReference type="PubMed" id="15146077"/>
<dbReference type="DOI" id="10.1261/rna.7320604"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH THE U11/U12 SPLICEOSOME</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435 AND SER-436</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="8149" last="8158">
<title>Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.</title>
<authorList>
<person name="Terada Y."/>
<person name="Yasuda Y."/>
</authorList>
<dbReference type="PubMed" id="16923959"/>
<dbReference type="DOI" id="10.1128/mcb.01170-06"/>
</citation>
<scope>INTERACTION WITH HIV-1 VPR (MICROBIAL INFECTION)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289; SER-307; SER-309; THR-311 AND THR-780</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
<title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
<authorList>
<person name="Han G."/>
<person name="Ye M."/>
<person name="Zhou H."/>
<person name="Jiang X."/>
<person name="Feng S."/>
<person name="Jiang X."/>
<person name="Tian R."/>
<person name="Wan D."/>
<person name="Zou H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="18318008"/>
<dbReference type="DOI" id="10.1002/pmic.200700884"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435 AND SER-436</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-309; SER-360; SER-362 AND THR-780</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-275</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-309; SER-431; SER-435; SER-436 AND THR-780</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435 AND SER-436</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289; THR-298; SER-307; SER-309; THR-311; SER-317; SER-431; SER-435; SER-436; THR-780 AND SER-861</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-311; SER-431; SER-435 AND SER-436</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-222; ARG-245; ARG-247 AND ARG-515</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-412</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-400</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-400</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-10; LYS-280; LYS-400; LYS-412; LYS-492; LYS-543; LYS-770; LYS-790; LYS-843 AND LYS-857</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="submission" date="2007-04" db="PDB data bank">
<title>Solution structure of the SAP domain of human splicing factor 3B subunit 2.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 24-68</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="6428" last="6428">
<title>PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145.</title>
<authorList>
<person name="Yang Y."/>
<person name="Hadjikyriacou A."/>
<person name="Xia Z."/>
<person name="Gayatri S."/>
<person name="Kim D."/>
<person name="Zurita-Lopez C."/>
<person name="Kelly R."/>
<person name="Guo A."/>
<person name="Li W."/>
<person name="Clarke S.G."/>
<person name="Bedford M.T."/>
</authorList>
<dbReference type="PubMed" id="25737013"/>
<dbReference type="DOI" id="10.1038/ncomms7428"/>
</citation>
<scope>METHYLATION AT ARG-508 BY PRMT9</scope>
<scope>MUTAGENESIS OF ARG-471; ARG-495; ARG-502; ARG-508; ARG-515; ARG-530 AND ARG-537</scope>
<scope>INTERACTION WITH SMN1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PRMT9; SF3B2 AND SF3B4</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="16723" last="16743">
<title>Unique features of human protein arginine methyltransferase 9 (PRMT9) and its substrate RNA splicing factor SF3B2.</title>
<authorList>
<person name="Hadjikyriacou A."/>
<person name="Yang Y."/>
<person name="Espejo A."/>
<person name="Bedford M.T."/>
<person name="Clarke S.G."/>
</authorList>
<dbReference type="PubMed" id="25979344"/>
<dbReference type="DOI" id="10.1074/jbc.m115.659433"/>
</citation>
<scope>MUTAGENESIS OF PHE-506; LYS-507; ARG-508; LYS-509 AND TYR-510</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0128558" last="E0128558">
<title>Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.</title>
<authorList>
<person name="Nicolai S."/>
<person name="Filippi S."/>
<person name="Caputo M."/>
<person name="Cipak L."/>
<person name="Gregan J."/>
<person name="Ammerer G."/>
<person name="Frontini M."/>
<person name="Willems D."/>
<person name="Prantera G."/>
<person name="Balajee A.S."/>
<person name="Proietti-De-Santis L."/>
</authorList>
<dbReference type="PubMed" id="26030138"/>
<dbReference type="DOI" id="10.1371/journal.pone.0128558"/>
</citation>
<scope>INTERACTION WITH ERCC6</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2016" name="Mol. Cell" volume="64" first="307" last="319">
<title>Molecular architecture of SF3b and structural consequences of its cancer-related mutations.</title>
<authorList>
<person name="Cretu C."/>
<person name="Schmitzova J."/>
<person name="Ponce-Salvatierra A."/>
<person name="Dybkov O."/>
<person name="De Laurentiis E.I."/>
<person name="Sharma K."/>
<person name="Will C.L."/>
<person name="Urlaub H."/>
<person name="Luehrmann R."/>
<person name="Pena V."/>
</authorList>
<dbReference type="PubMed" id="27720643"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.08.036"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="13573" last="13573">
<title>Structure of the RBM7-ZCCHC8 core of the NEXT complex reveals connections to splicing factors.</title>
<authorList>
<person name="Falk S."/>
<person name="Finogenova K."/>
<person name="Melko M."/>
<person name="Benda C."/>
<person name="Lykke-Andersen S."/>
<person name="Jensen T.H."/>
<person name="Conti E."/>
</authorList>
<dbReference type="PubMed" id="27905398"/>
<dbReference type="DOI" id="10.1038/ncomms13573"/>
</citation>
<scope>INTERACTION WITH RBM7</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Nat. Commun." volume="8" first="15522" last="15522">
<title>Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.</title>
<authorList>
<person name="Teng T."/>
<person name="Tsai J.H."/>
<person name="Puyang X."/>
<person name="Seiler M."/>
<person name="Peng S."/>
<person name="Prajapati S."/>
<person name="Aird D."/>
<person name="Buonamici S."/>
<person name="Caleb B."/>
<person name="Chan B."/>
<person name="Corson L."/>
<person name="Feala J."/>
<person name="Fekkes P."/>
<person name="Gerard B."/>
<person name="Karr C."/>
<person name="Korpal M."/>
<person name="Liu X."/>
<person name="Lowe J.T."/>
<person name="Mizui Y."/>
<person name="Palacino J."/>
<person name="Park E."/>
<person name="Smith P.G."/>
<person name="Subramanian V."/>
<person name="Wu Z.J."/>
<person name="Zou J."/>
<person name="Yu L."/>
<person name="Chicas A."/>
<person name="Warmuth M."/>
<person name="Larsen N."/>
<person name="Zhu P."/>
</authorList>
<dbReference type="PubMed" id="28541300"/>
<dbReference type="DOI" id="10.1038/ncomms15522"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="20 22 24 29">Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex (PubMed:27720643). SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). May also be involved in the assembly of the 'E' complex (PubMed:10882114). Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron (PubMed:15146077).</text>
</comment>
<comment type="subunit">
<text evidence="21 22 23 24 26 28 29 30 31">Identified in the spliceosome C complex (PubMed:11991638). Component of the U11/U12 snRNPs that are part of the U12-type spliceosome (PubMed:15146077). Component of splicing factor SF3B which is composed of at least eight subunits; SF3B1, SF3B2, SF3B3, SF3B4, SF3B5, SF3B6, PHF5A and DDX42 (PubMed:12234937, PubMed:12738865, PubMed:27720643, PubMed:28541300). SF3B associates with the splicing factor SF3A and a 12S RNA unit to form the U2 small nuclear ribonucleoproteins complex (U2 snRNP) (PubMed:12234937). Interacts directly with SF3B4 (PubMed:25737013). The SF3B complex composed of SF3B1, SF3B2, SF3B3, SF3B4, SF3B5, SF3B6 and PHF5A interacts with U2AF2 (PubMed:27720643). Found in a complex with PRMT9, SF3B2 and SF3B4 (PubMed:25737013). Interacts (Arg-508-methylated form) with SMN1 (via Tudor domain) (PubMed:25737013). Interacts with RBM7 (PubMed:27905398). Interacts with ERCC6 (PubMed:26030138).</text>
</comment>
<comment type="subunit">
<text evidence="25">(Microbial infection) Interacts with HIV-1 Vpr.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-311446">
<id>O60231</id>
<label>DHX16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-710176">
<id>Q70Z53</id>
<label>FRA10AC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-710124">
<id>O60341</id>
<label>KDM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-744322">
<id>O43395</id>
<label>PRPF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-538479">
<id>Q6P2Q9</id>
<label>PRPF8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-2130294">
<id>O15541</id>
<label>RNF113A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-348469">
<id>Q15427</id>
<label>SF3B4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-750559">
<id>O95391</id>
<label>SLU7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-632461">
<id>Q01081</id>
<label>U2AF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-295232">
<id>Q9HCS7</id>
<label>XAB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-749111">
<id>Q13435</id>
</interactant>
<interactant intactId="EBI-3920997">
<id>Q96NB3</id>
<label>ZNF830</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="29 31">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="25">Nucleus speckle</location>
</subcellularLocation>
</comment>
<comment type="PTM">
<text evidence="26">Methylation at Arg-508 by PRMT9 is required for the interaction with SMN1.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA97461" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAA97461" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH53577" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG61831" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EMBL" id="AK290850">
<property type="protein sequence ID" value="BAF83539.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300016">
<property type="protein sequence ID" value="BAG61831.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000401">
<property type="protein sequence ID" value="AAH00401.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007610">
<property type="protein sequence ID" value="AAH07610.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014125">
<property type="protein sequence ID" value="AAH14125.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC053577">
<property type="protein sequence ID" value="AAH53577.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U41371">
<property type="protein sequence ID" value="AAA97461.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31612.1"/>
<dbReference type="RefSeq" id="NP_006833.2">
<property type="nucleotide sequence ID" value="NM_006842.2"/>
</dbReference>
<dbReference type="PDB" id="2DO5">
<property type="method" value="NMR"/>
<property type="chains" value="A=24-68"/>
</dbReference>
<dbReference type="PDB" id="5Z56">
<property type="method" value="EM"/>
<property type="resolution" value="5.10"/>
<property type="chains" value="2=1-895"/>
</dbReference>
<dbReference type="PDB" id="5Z57">
<property type="method" value="EM"/>
<property type="resolution" value="6.50"/>
<property type="chains" value="2=1-895"/>
</dbReference>
<dbReference type="PDB" id="5Z58">
<property type="method" value="EM"/>
<property type="resolution" value="4.90"/>
<property type="chains" value="2=1-895"/>
</dbReference>
<dbReference type="PDB" id="6AH0">
<property type="method" value="EM"/>
<property type="resolution" value="5.70"/>
<property type="chains" value="2=1-895"/>
</dbReference>
<dbReference type="PDB" id="6FF4">
<property type="method" value="EM"/>
<property type="resolution" value="16.00"/>
<property type="chains" value="8=1-895"/>
</dbReference>
<dbReference type="PDB" id="6FF7">
<property type="method" value="EM"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="8=1-895"/>
</dbReference>
<dbReference type="PDB" id="6QX9">
<property type="method" value="EM"/>
<property type="resolution" value="3.28"/>
<property type="chains" value="B2=1-895"/>
</dbReference>
<dbReference type="PDB" id="6Y50">
<property type="method" value="EM"/>
<property type="resolution" value="4.10"/>
<property type="chains" value="8=1-895"/>
</dbReference>
<dbReference type="PDB" id="6Y53">
<property type="method" value="EM"/>
<property type="resolution" value="7.10"/>
<property type="chains" value="8=1-895"/>
</dbReference>
<dbReference type="PDB" id="6Y5Q">
<property type="method" value="EM"/>
<property type="resolution" value="7.10"/>
<property type="chains" value="8=1-895"/>
</dbReference>
<dbReference type="PDBsum" id="2DO5"/>
<dbReference type="PDBsum" id="5Z56"/>
<dbReference type="PDBsum" id="5Z57"/>
<dbReference type="PDBsum" id="5Z58"/>
<dbReference type="PDBsum" id="6AH0"/>
<dbReference type="PDBsum" id="6FF4"/>
<dbReference type="PDBsum" id="6FF7"/>
<dbReference type="PDBsum" id="6QX9"/>
<dbReference type="PDBsum" id="6Y50"/>
<dbReference type="PDBsum" id="6Y53"/>
<dbReference type="PDBsum" id="6Y5Q"/>
<dbReference type="SMR" id="Q13435"/>
<dbReference type="BioGRID" id="116188">
<property type="interactions" value="273"/>
</dbReference>
<dbReference type="CORUM" id="Q13435"/>
<dbReference type="IntAct" id="Q13435">
<property type="interactions" value="90"/>
</dbReference>
<dbReference type="MINT" id="Q13435"/>
<dbReference type="STRING" id="9606.ENSP00000318861"/>
<dbReference type="ChEMBL" id="CHEMBL1229011"/>
<dbReference type="iPTMnet" id="Q13435"/>
<dbReference type="MetOSite" id="Q13435"/>
<dbReference type="PhosphoSitePlus" id="Q13435"/>
<dbReference type="SwissPalm" id="Q13435"/>
<dbReference type="BioMuta" id="SF3B2"/>
<dbReference type="DMDM" id="296452908"/>
<dbReference type="EPD" id="Q13435"/>
<dbReference type="jPOST" id="Q13435"/>
<dbReference type="MassIVE" id="Q13435"/>
<dbReference type="MaxQB" id="Q13435"/>
<dbReference type="PaxDb" id="Q13435"/>
<dbReference type="PeptideAtlas" id="Q13435"/>
<dbReference type="PRIDE" id="Q13435"/>
<dbReference type="ProteomicsDB" id="59431"/>
<dbReference type="TopDownProteomics" id="Q13435"/>
<dbReference type="Antibodypedia" id="30058">
<property type="antibodies" value="205 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10992"/>
<dbReference type="Ensembl" id="ENST00000322535">
<property type="protein sequence ID" value="ENSP00000318861"/>
<property type="gene ID" value="ENSG00000087365"/>
</dbReference>
<dbReference type="GeneID" id="10992"/>
<dbReference type="KEGG" id="hsa:10992"/>
<dbReference type="UCSC" id="uc001ogy.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10992"/>
<dbReference type="DisGeNET" id="10992"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000087365.14"/>
<dbReference type="GeneCards" id="SF3B2"/>
<dbReference type="HGNC" id="HGNC:10769">
<property type="gene designation" value="SF3B2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000087365">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="605591">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13435"/>
<dbReference type="OpenTargets" id="ENSG00000087365"/>
<dbReference type="PharmGKB" id="PA35687"/>
<dbReference type="eggNOG" id="KOG2330">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000006734"/>
<dbReference type="InParanoid" id="Q13435"/>
<dbReference type="KO" id="K12829"/>
<dbReference type="OMA" id="MYRQFYR"/>
<dbReference type="OrthoDB" id="1275099at2759"/>
<dbReference type="PhylomeDB" id="Q13435"/>
<dbReference type="TreeFam" id="TF300635"/>
<dbReference type="PathwayCommons" id="Q13435"/>
<dbReference type="Reactome" id="R-HSA-72163">
<property type="pathway name" value="mRNA Splicing - Major Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72165">
<property type="pathway name" value="mRNA Splicing - Minor Pathway"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="10992">
<property type="hits" value="724 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SF3B2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q13435"/>
<dbReference type="GeneWiki" id="SF3B2"/>
<dbReference type="GenomeRNAi" id="10992"/>
<dbReference type="Pharos" id="Q13435">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13435"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q13435">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000087365">
<property type="expression patterns" value="Expressed in testis and 243 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13435">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13435">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0071013">
<property type="term" value="C:catalytic step 2 spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071011">
<property type="term" value="C:precatalytic spliceosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005681">
<property type="term" value="C:spliceosomal complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005689">
<property type="term" value="C:U12-type spliceosomal complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005686">
<property type="term" value="C:U2 snRNP"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071005">
<property type="term" value="C:U2-type precatalytic spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005684">
<property type="term" value="C:U2-type spliceosomal complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000398">
<property type="term" value="P:mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008380">
<property type="term" value="P:RNA splicing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR007180">
<property type="entry name" value="DUF382"/>
</dbReference>
<dbReference type="InterPro" id="IPR006568">
<property type="entry name" value="PSP_pro-rich"/>
</dbReference>
<dbReference type="InterPro" id="IPR003034">
<property type="entry name" value="SAP_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF04037">
<property type="entry name" value="DUF382"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04046">
<property type="entry name" value="PSP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02037">
<property type="entry name" value="SAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00581">
<property type="entry name" value="PSP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00513">
<property type="entry name" value="SAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50800">
<property type="entry name" value="SAP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0747">Spliceosome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Splicing factor 3B subunit 2" id="PRO_0000174328">
<location>
<begin position="1"/>
<end position="895"/>
</location>
</feature>
<feature type="domain" description="SAP" evidence="19">
<location>
<begin position="24"/>
<end position="58"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with PRMT9" evidence="26">
<location>
<begin position="401"/>
<end position="550"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="18">
<location>
<begin position="140"/>
<end position="199"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="16"/>
<end position="21"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="91"/>
<end position="96"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="104"/>
<end position="113"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="129"/>
<end position="132"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="249"/>
<end position="253"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="292"/>
<end position="297"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="331"/>
<end position="335"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="699"/>
<end position="702"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="720"/>
<end position="726"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="245"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="247"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="275"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 11">
<location>
<position position="289"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="298"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 9 11">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 9 11">
<location>
<position position="309"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 11 13">
<location>
<position position="311"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="317"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="360"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="362"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 9 10 11 13">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 9 10 11 13">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 9 10 11 13">
<location>
<position position="436"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT9; alternate" evidence="26">
<location>
<position position="508"/>
</location>
</feature>
<feature type="modified residue" description="Symmetric dimethylarginine; by PRMT9; alternate" evidence="26">
<location>
<position position="508"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="515"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 8 9 11">
<location>
<position position="780"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="861"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="10"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="280"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15 16 17">
<location>
<position position="400"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14 17">
<location>
<position position="412"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="492"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="543"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="770"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="790"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="843"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="857"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9; when associated with A-510." evidence="27">
<original>F</original>
<variation>A</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with A-509." evidence="27">
<original>K</original>
<variation>A</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with R-509. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-508. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with K-508 and R-509." evidence="27">
<original>K</original>
<variation>R</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SMN1; Abolishes methylation by PRMT9. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507 and R-509." evidence="26 27">
<original>R</original>
<variation>K</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with A-507." evidence="26">
<original>K</original>
<variation>A</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with K-508 and R-507." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9; when associated with A-506." evidence="27">
<original>Y</original>
<variation>A</variation>
<location>
<position position="510"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by PRMT9." evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="537"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAF83539." ref="1" evidence="32">
<original>K</original>
<variation>E</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAF83539." ref="1" evidence="32">
<original>E</original>
<variation>G</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="29"/>
<end position="39"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="47"/>
<end position="61"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="462"/>
<end position="468"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="479"/>
<end position="481"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="482"/>
<end position="484"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="485"/>
<end position="491"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="492"/>
<end position="496"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="502"/>
<end position="504"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="509"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="526"/>
<end position="529"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="530"/>
<end position="532"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="533"/>
<end position="544"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="549"/>
<end position="554"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="555"/>
<end position="557"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="569"/>
<end position="576"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="593"/>
<end position="597"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DO5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6FF4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18318008"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255"/>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00186"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10882114"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11991638"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12234937"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12738865"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15146077"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16923959"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25737013"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25979344"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26030138"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27720643"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27905398"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28541300"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="895" mass="100228" checksum="D372AFA679443AD6" modified="2010-05-18" version="2">MATEHPEPPKAELQLPPPPPPGHYGAWAAQELQAKLAEIGAPIQGNREELVERLQSYTRQTGIVLNRPVLRGEDGDKAAPPPMSAQLPGIPMPPPPLGLPPLQPPPPPPPPPPGLGLGFPMAHPPNLGPPPPLRVGEPVALSEEERLKLAQQQAALLMQQEERAKQQGDHSLKEHELLEQQKRAAVLLEQERQQEIAKMGTPVPRPPQDMGQIGVRTPLGPRVAAPVGPVGPTPTVLPMGAPVPRPRGPPPPPGDENREMDDPSVGPKIPQALEKILQLKESRQEEMNSQQEEEEMETDARSSLGQSASETEEDTVSVSKKEKNRKRRNRKKKKKPQRVRGVSSESSGDREKDSTRSRGSDSPAADVEIEYVTEEPEIYEPNFIFFKRIFEAFKLTDDVKKEKEKEPEKLDKLENSAAPKKKGFEEEHKDSDDDSSDDEQEKKPEAPKLSKKKLRRMNRFTVAELKQLVARPDVVEMHDVTAQDPKLLVHLKATRNSVPVPRHWCFKRKYLQGKRGIEKPPFELPDFIKRTGIQEMREALQEKEEQKTMKSKMREKVRPKMGKIDIDYQKLHDAFFKWQTKPKLTIHGDLYYEGKEFETRLKEKKPGDLSDELRISLGMPVGPNAHKVPPPWLIAMQRYGPPPSYPNLKIPGLNSPIPESCSFGYHAGGWGKPPVDETGKPLYGDVFGTNAAEFQTKTEEEEIDRTPWGELEPSDEESSEEEEEEESDEDKPDETGFITPADSGLITPGGFSSVPAGMETPELIELRKKKIEEAMDGSETPQLFTVLPEKRTATVGGAMMGSTHIYDMSTVMSRKGPAPELQGVEVALAPEELELDPMAMTQKYEEHVREQQAQVEKEDFSDMVAEHAAKQKQKKRKAQPQDSRGGSKKYKEFKF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

